Sign In
Buy ACT
$40.57
-0.580 (-1.41%)
At Close: Jun 03, 2026
BRIEF-Allergan PLC Says On April 21 Sent A Notice To Its Directors And Its Officers
10:40pm, Tuesday, 21'st Apr 2020
Allergan plc:
Emergent BioSolutions Appoints Dr. Karen L. Smith as Chief Medical Officer
08:55pm, Tuesday, 21'st Apr 2020
Emergent BioSolutions Inc. (EBS) today announced the appointment of Dr. Karen L. Smith, M.D., Ph.D. as chief medical officer with responsibility for leading and further establishing Emergent’s globa
Allergan’s Acquisition by AbbVie Will Close Soon. Why One Analyst Just Downgraded Its Stock.
05:36pm, Tuesday, 21'st Apr 2020
SunTrust Robinson Humphrey analyst sees potential upside in the shares of Allergan but also risk if the deal with AbbVie falls through.
8 Safe High-Yield Dividend Stocks Offering 5% or More
04:02pm, Tuesday, 21'st Apr 2020
Steep market declines in 2020 have not only been brutal on returns; they've also presented income investors with a conundrum. The market is suddenly flooded with a glut of high-yield dividend stocks,
Form 8.3 -
03:30pm, Tuesday, 21'st Apr 2020
FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH.
Davidson Kempner Capital Management LP : Form 8.3 - Allergan PLC
02:20pm, Tuesday, 21'st Apr 2020
Ap19FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH...
MILLENNIUM PARTNERS, L.P. UK Regulatory Announcement: Form 8.3 - Allergan plc
02:15pm, Tuesday, 21'st Apr 2020
FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERES
Outlook Therapeutics Bolsters Clinical and Commercial Expertise with Two Key Appointments to Board of Directors
12:05pm, Tuesday, 21'st Apr 2020
Outlook Therapeutics, Inc. (OTLK) (the “Company”), a late clinical-stage biopharmaceutical company working to develop the first FDA-approved ophthalmic formulation of bevacizumab for use in
Global Antidepressants Market (2020 to 2030) - COVID-19 Implications and Growth
12:03pm, Tuesday, 21'st Apr 2020
Dublin, April 21, 2020 -- The "Antidepressants Global Market Report 2020-30: Covid 19 Implications and Growth" report has been added to ResearchAndMarkets.com's.
Allergan downgraded to Hold from Buy at SunTrust AGN;ABBV
11:30am, Tuesday, 21'st Apr 2020
Allergan downgraded to Hold from Buy at SunTrust SunTrust AGN ABBV
Allergan downgraded to Hold from Buy at SunTrust AGN
11:18am, Tuesday, 21'st Apr 2020
Allergan downgraded to Hold from Buy at SunTrust SunTrust AGN
Edge Wealth Management LLC Has $67,000 Stock Holdings in Allergan plc (NYSE:AGN)
09:30am, Tuesday, 21'st Apr 2020
Edge Wealth Management LLC decreased its stake in Allergan plc (NYSE:AGN) by 99.1% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commissio
Adverum Biotechnologies Appoints Ophthalmology Industry Veteran Scott Whitcup, M.D. to Board of Directors
08:05pm, Monday, 20'th Apr 2020
Adverum Biotechnologies, Inc. (ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced the appointment of Scott Whitcup, M.D. to the Com
Buy AbbVie Stock as the Drugmaker Diversifies Its Pipeline
07:41pm, Monday, 20'th Apr 2020
With a major acquisition in the works, ABBV stock isn't just a dividend king, but a rapidly-diversifying juggernaut.
The "Biosimilars Market Global Report 2020-30" report has been added to ResearchAndMarkets.com's offering.
